Last reviewed · How we verify
NCT02630225: HIFI
Helping Individuals With Firearm Injuries
NA trial testing Critical Time Intervention in Wounds, Gunshot in 232 participants. Completed in 31 December 2019.
30 June 2019
Quick facts
| Lead sponsor | University of Washington |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 232 |
| Start date | 23 March 2016 |
| Primary completion | 30 June 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Critical Time Intervention
- Treatment as Usual
- Motivational Interviewing
- Multi-Agency Attention
Conditions studied
- Wounds, Gunshot — all drugs for Wounds, Gunshot →
Sponsor
University of Washington
Who can join
18 and older, any sex, with Wounds, Gunshot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will conduct a cluster randomized trial of an intervention program that combines a hospital-based intervention, structured outreach program, and multi-agency attention. The goal of the study is to test the effect of this multi-component intervention on criminal activity, injury, substance abuse, mental health, quality of life, violent behavior, and death. Investigators aim to enroll a total of 300 patients admitted to the Harborview Medical Center (HMC) for firearm-related injuries. Patients will be randomized to receive a multi-component intervention or treatment as usual. All participants will complete surveys at the time of study consent (baseline) and then at designated time points for 12 months post-consent. Study staff will routinely collect participant records from Washington State Patrol records, HMC medical records, Washington State trauma registry, Washington State Emergency Department Information Exchange, Administrative Office of the Courts, and vital records. The investigators will test the impact of the intervention against standard care. The hypothesis is that participants in the intervention group will see greater improvements in aforementioned outcomes than those in the control group.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Helping individuals with firearm injuries: A cluster randomized trial.
Lyons VH, Floyd AS, Griffin E, Wang J, et al · · 2021 · cited 17× · PMID 33405475 · DOI 10.1097/ta.0000000000003056 -
Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuries.
Floyd AS, Lyons VH, Whiteside LK, Haggerty KP, et al · · 2021 · cited 5× · PMID 34304738 · DOI 10.1186/s40621-021-00331-z
Verify or expand the search:
- PubMed search for NCT02630225
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Critical Time Intervention
Trials testing the same drug.
- NCT05312229 — Housing Transitions QUERI · Phase 1 · enrolling by invitation
Other University of Washington trials
Trials by the same sponsor.
- NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
- NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
- NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
- NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02630225 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Washington
- Last refreshed: 6 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02630225.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing